Full Course Description

Asthma Education with Passion: The Journey Towards Asthma Control

Learn how you can improve your asthma education and help your patients prevent repeated use of the emergency room for asthma exacerbations and reduce risk of asthma mortality. Explore how the partnership between the clinician and the patient makes all the difference in the asthma self-management journey for the patient. You can lead your patients towards asthma control, expand your role in asthma care, and make a significant impact in patient outcomes.

Program Information

Target Audience

Nurses
Nurse practitioners
Physician assistants
Asthma educators
Respiratory therapists
Other clinicians who care for patients with asthma.

Outline

Asthma Overview

Pathophysiology, Statistics, Facts
Disparities
Precision Medicine…Phenotypes, Endotypes, Biomarkers
Asthma Diagnosis

Asthma Management

Triggers
Allergies/Allergy Testing
Comorbid Conditions
Guidelines

Asthma Education

Health Belief Model
Developing a Plan
Partnership with Patient
Overcoming Barriers

Chronic Care Module

Developing an Educational Program
Resources
Linkages of Care
Referrals and Networking

Objectives

Discuss concepts from the Expert Panel Review 4 (EPR 4 ) education for a partnership in asthma care.
Describe the significance of motivational interviewing in chronic disease management.
List two socioeconomic barriers to care provision for vulnerable patient populations.
Describe different inhaler techniques.
Recognize the most appropriate device for each patient.
Explain how to apply the concepts from the Chronic Care Model and Health Belief Model.

Copyright : 09/27/2023

Asthma Management and Medication Devices

Asthma management is an ever-evolving field with new medications, guidelines, and strategies...making it hard to find the information you need. Look no further! This course is designed to empower clinicians like you with the latest knowledge and skills needed to stay ahead of the curve and prescribe confidently by exploring the current recommendations and latest advancements in asthma treatment, including precision medicine.

Program Information

Objectives

Determine the medications used in the treatment of asthma, their mechanism of action, and adverse effects
Describe different inhaler techniques used by patients with asthma.
Recognize the most appropriate device for delivery of asthma medication based on patient’s condition. .
Discuss emerging therapies for asthma, specifically the role of biologic agents, including guideline recommendations and supporting clinical evidence.

Outline

Asthma Management and Medication Devices

Classification
Stepwise approach
Short-acting beta agonists (SABA)
Inhaled Corticosteroids (ICS)
Biologics

Latest-Evidence/Guidelines

Single Maintenance and Reliever Therapy (SMART)
Global Initiative for Asthma (GINA)
National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) Expert Panel 4 (EPR-4)

Target Audience

Nurses
Nurse Practitioners
Physician Assistants
Asthma Educators
Respiratory Therapists
Other Clinicians Who Care For Patients With Asthma

Copyright : 09/27/2023

Asthma Interventions

Everything you have known and practiced in the management of asthma for the past 50 years is no longer relevant! The Global Initiative for Asthma (GINA) Guidelines have totally revamped the approach to asthma management and as a primary care provider, this is information you absolutely need to know. In this session, you will learn the current asthma treatment strategies with the goal of preventing deaths and exacerbations, with new guidelines for prescribing albuterol as a rescue inhaler. You will walk away with a new understanding of the best way to manage asthma in 2023 and beyond!

Program Information

Objectives

Determine goals of asthma therapy as it relates to the GINA Strategy.
Analyze why SABAs have been demoted as a rescue inhaler in the management of asthma.
Determine the LABA-ICS of choice according to the GINA Strategy.
Evaluate with monotherapy asthma inhaler class is contraindicated in the management of asthma.

Outline

What is GINA?

Discuss Anti-Asthmatic Drugs and how they are employed in the GINA strategy

SABAs
LABAs + ICS
LAAC
ICS
LTR

Discuss how the GINA Strategy has changed the use of albuterol in the management of asthma

Compare previous asthma treatment guidelines to the current GINA strategy

Discuss the US Boxed Warning associated with LABAs in the management of asthma

Discuss alternative asthma treatments/other controller options employed in the GINA Strategy

Target Audience

Nurses
Nurse Practitioners
Physician Assistants
Physicians
Respiratory Therapists

Copyright : 05/11/2023

Respiratory Pharmacology: Pharmacokinetics, Indications for Use and Patient Monitoring

Have you ever felt a lack of confidence when prescribing pulmonary medications? You are not alone… During this Summit session, Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, will take you through laboratory data, testing results and physical assessment findings to determine the appropriate respiratory diagnosis. From there, you will take away the very latest updates to guide prescriptive decisions for the most common respiratory conditions you see in practice – asthma, COPD, COVID-19, TB, pulmonary hypertension, & pneumonia. This jam-packed presentation is sure to leave you with new insights and evidence guidelines to support patients optimally.

Program Information

Objectives

Determine the best medications to use during acute asthma attack.
Manage the current recommended medications for the COVID-19 patient both out- and in-patient.
Formulate a medication regimen for a tuberculosis patient, both newly diagnosed and with drug-resistant tuberculosis.
Devise the treatment protocol for a patient with pulmonary hypertension.
Plan for optimal antibiotic selection for the patient with bacterial pneumonia.

Outline

Asthma – Not Just Bronchodilators Anymore

How is asthma diagnosed?
Global Initiative for Asthma (GINA) medication options
Role of corticosteroids in asthma treatment
Short acting beta agonists (SABA), long-acting beta agonists (LABA) - the difference and monitoring parameters
Muscarinic antagonists, leukotriene modifiers and phosphodiesterase inhibitors - must know indications and contraindications
Monoclonal antibodies for asthma relief

Chronic Obstructive Pulmonary Disease (COPD) – Long Term Pharmacologic Therapies

COPD causes, symptoms and diagnostic tests
Non-pharmacologic treatments
SABA and LABA - when and how much
Inhaled corticosteroids alone or in combination with bronchodilators
Vaccines are a must – which ones and at what age to administer

SARS-CoV2, COVID-19

Laboratory parameters for SARS-CoV2
How effective are all those COVID-19 vaccines
Which antiviral medications are FDA approved and which are still in clinical trials?
Dexamethasone is effective - but only in certain patient populations

Tuberculosis (TB): Still Prevalent and Highly Contagious

What is Mycobacterium tuberculosis and how is it detected?
First line medications for drug susceptible TB (doses, how often & how long to take)
Multi-drug resistant TB treatments

Pulmonary Hypertension

Diagnosis of pulmonary hypertension
12-lead ECG results in a patient with pulmonary hypertension
Select between calcium channel blockers, phosphodiesterase inhibitors, endothelin receptor antagonizes and prostacyclin agonists

Pneumonia

Community acquired treatment options
Antibiotic options based on patient history
Hospital acquired pharmacology
How to treat methicillin resistant staphylococcus aureus

Target Audience

Nurses
Nurse Practitioners
Pharmacists
Physicians
Physician Assistants
Respiratory Therapists

Copyright : 05/19/2022

Pediatric Respiratory Conditions: Challenges in Managing Upper versus Lower Airways

Children are not small adults, and infants are not small children. Each are unique and require different interventions and treatment modalities. In today’s managed care and “decreased length of stay” environment, it is imperative that nurses and other healthcare providers in all health care settings-from home to primary care to acute care-be prepared to identify and intervene with respiratory situations as early as possible.

Secondary to both anatomical and physiological etiologies, children with respiratory conditions may present with acute illnesses, flare-ups of chronic conditions or life-threatening complications. As an example: the latest statistics indicate that about 1 in 10 children in the United States have a diagnosis of asthma. Rapid assessment and immediate intervention is oftentimes vital; yet long term chronic mismanagement can lead to significant issues. You will learn practical strategies to integrate symptomology and appropriate diagnostics into your differential diagnosis; enhance your ability to pinpoint etiology by understanding the inter-relationship of respiratory signs and symptoms; and to differentiate when to treat “cause” versus “symptom.”

This seminar will provide you with the knowledge you need to manage numerous respiratory conditions that are the cause for children seeking health care, and oftentimes hospitalization. You will receive the latest information on:

Traditional, improved and new medications and devices
Urgent and emergent management and interventions
Distinguishing between the “linked” airway disorders that determine upper versus lower airway etiology and manifestations

Your speaker Stephen Jones will discuss some of the pharmacological and non-pharmacological treatments for upper and lower respiratory conditions. He will help you identify the role of appropriate oxygen therapy in numerous situations, and to understand PFT’s and various technologies that are utilized when managing children with pulmonary issues. Discover what the pulse oximeter really signifies! Stephen’s long-standing passion for optimal pediatric care will be evident throughout this presentation.

His vast experiences and clinical management of these children will be shared, in a professional, educational yet fun learning experience. He is excited to share his wealth of knowledge, and help spread the “evidence based” word! In this endeavor, Stephen will provide the skills and knowledge for you to improve the outcomes of these children, and minimize negative sequalae. We know that you will find him positive, upbeat, energetic, full of evidence based information, practical, motivating, humorous, and willing to go the extra mile to make this program as success!

TOP 5 PROBLEMS this program will seek to solve:

Gain an understanding of the manifestations of upper and lower respiratory conditions.
Learn the evidence behind the recommended management guidelines.
Describe and examine the step management for asthma.
Identify appropriate non-pharmacological and pharmacological interventions for respiratory conditions
Prevent misuse of non-evidence-based interventions

Program Information

Objectives

Discuss the importance of the physical exam, history and basic diagnostic tests.
Assess and evaluate the underlying causes and triggers for common upper and lower respiratory conditions.
Differentiate between signs and symptoms, as opposed to the “cause”, for upper and lower respiratory conditions.
Discuss the appropriate utilization of various technologies used with respiratory conditions and their clinical significance.
Recommend appropriate interventions for the child manifesting either an upper or lower respiratory condition.

Outline

History taking and physical assessment

Developmentally and age appropriate techniques
Determining cause versus symptom and the ‘inflammatory response”
Differentiating Upper versus Lower respiratory conditions
”5 Fingered assessment”

Non-pharmacological: airway/ENT medications, airway clearance, pulse oximeter

Oxygen therapy: devises, flow rates
mist/humidification
Asthma meds and devised used (MDI/spacer, DPI, nebulizer)
Chest physiotherapy; concepts and products

Pharmacological Choices: OTC versus prescription

Antimicrobials (anti-bacterial, anti-viral, anti-fungal)
Reactive airways: rescue versus controller medications
”cold and cough” medications

Laboratory Values

Significance of numbers
CBC, RAST testing, Immunoglobins

Underlying triggers

Environmental
Infectious
Anatomical
Hygiene hypothesis

Apnea: central and obstructive

Upper respiratory conditions

Pathophysiology of airways
Infectious ENT related: sinusitis, tonsillitis
Croup and laryngomalacia
Evidence based management

Lower respiratory conditions

Pathophysiology of airways
Infectious: bronchiolitis/RSV and HMV; pneumonia
Anatomical: asthma
Evidence based management, “step management” for asthma

Target Audience

Nurses
NPs
APRNs
Physician Assistants
Physicians
Respiratory Therapists

Managing COPD in Primary Care

COPD is a leading cause of morbidity and mortality in the United States and around the world. Unfortunately, many clinicians do not have the time or resources to optimally manage this complex disease. This presentation will provide an overview of COPD pathophysiology as well as best practices for managing the condition, including pharmacological, non-pharmacological, and advanced interventions. The presentation is designed to give busy clinicians immediately actionable recommendations to enhance patient care for the COPD community.

Program Information

Objectives

Determine potential cases of COPD and pre-COPD in their patient panels.
Optimize medication management (including determining the best aerosol delivery device for each patient).
Integrate more non-pharmacological interventions for patients including pulmonary rehabilitation and bronchoscopic lung volume reduction.

Outline

COPD Pathogenesis & Epidemiology

Screening tools
Phenotypes/etiotypes
Diagnostic options

Treatment Options

Pharmacological management
Tobacco cessation strategies
Pulmonary rehabilitation
Oxygen therapy
Surgical and bronchoscopic interventions

Additional Resources

GOLD
ATS/ERS
Peer support groups

Target Audience

Nurses
Nurse Practitioners
Physician Assistants
Physicians
Respiratory Therapists